世界の皮膚糸状菌症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dermatophytosis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1807 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、皮膚糸状菌症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚糸状菌症治療の市場動向 ・企業の競争状況、市場シェア ・皮膚糸状菌症治療の種類別市場規模（Rx、OTC） ・皮膚糸状菌症治療の用途別市場規模（病院、クリニック、その他） ・皮膚糸状菌症治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚糸状菌症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚糸状菌症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚糸状菌症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚糸状菌症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Pfizer、Sanofi-Aventis、Merck、Enzon Pharmaceuticals、Bayer、Astellas Pharma、GSK、Abbott） ・結論

Ringworm on the skin like athlete’s foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.

Market Analysis and Insights: Global Dermatophytosis Therapeutics Market
The global Dermatophytosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatophytosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatophytosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatophytosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatophytosis Therapeutics market.

Global Dermatophytosis Therapeutics Scope and Market Size
Dermatophytosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Rx
OTC

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Dermatophytosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dermatophytosis Therapeutics Market Perspective (2016-2027)
2.2 Dermatophytosis Therapeutics Growth Trends by Regions
2.2.1 Dermatophytosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatophytosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Dermatophytosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Dermatophytosis Therapeutics Industry Dynamic
2.3.1 Dermatophytosis Therapeutics Market Trends
2.3.2 Dermatophytosis Therapeutics Market Drivers
2.3.3 Dermatophytosis Therapeutics Market Challenges
2.3.4 Dermatophytosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dermatophytosis Therapeutics Players by Revenue
3.1.1 Global Top Dermatophytosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Dermatophytosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Dermatophytosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatophytosis Therapeutics Revenue
3.4 Global Dermatophytosis Therapeutics Market Concentration Ratio
3.4.1 Global Dermatophytosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytosis Therapeutics Revenue in 2020
3.5 Dermatophytosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Dermatophytosis Therapeutics Product Solution and Service
3.7 Date of Enter into Dermatophytosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatophytosis Therapeutics Breakdown Data by Type
4.1 Global Dermatophytosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Dermatophytosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Dermatophytosis Therapeutics Breakdown Data by Application
5.1 Global Dermatophytosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Dermatophytosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dermatophytosis Therapeutics Market Size (2016-2027)
6.2 North America Dermatophytosis Therapeutics Market Size by Type
6.2.1 North America Dermatophytosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Dermatophytosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Dermatophytosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Dermatophytosis Therapeutics Market Size by Application
6.3.1 North America Dermatophytosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Dermatophytosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Dermatophytosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Dermatophytosis Therapeutics Market Size by Country
6.4.1 North America Dermatophytosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Dermatophytosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dermatophytosis Therapeutics Market Size (2016-2027)
7.2 Europe Dermatophytosis Therapeutics Market Size by Type
7.2.1 Europe Dermatophytosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Dermatophytosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Dermatophytosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Dermatophytosis Therapeutics Market Size by Application
7.3.1 Europe Dermatophytosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Dermatophytosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Dermatophytosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Dermatophytosis Therapeutics Market Size by Country
7.4.1 Europe Dermatophytosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Dermatophytosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dermatophytosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Dermatophytosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Dermatophytosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatophytosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatophytosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatophytosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Dermatophytosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatophytosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatophytosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatophytosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Dermatophytosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatophytosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dermatophytosis Therapeutics Market Size (2016-2027)
9.2 Latin America Dermatophytosis Therapeutics Market Size by Type
9.2.1 Latin America Dermatophytosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Dermatophytosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Dermatophytosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Dermatophytosis Therapeutics Market Size by Application
9.3.1 Latin America Dermatophytosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Dermatophytosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Dermatophytosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Dermatophytosis Therapeutics Market Size by Country
9.4.1 Latin America Dermatophytosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Dermatophytosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dermatophytosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Dermatophytosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Dermatophytosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatophytosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatophytosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatophytosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Dermatophytosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatophytosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatophytosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatophytosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Dermatophytosis Therapeutics Introduction
11.1.4 Novartis Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Dermatophytosis Therapeutics Introduction
11.2.4 Pfizer Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Details
11.3.2 Sanofi-Aventis Business Overview
11.3.3 Sanofi-Aventis Dermatophytosis Therapeutics Introduction
11.3.4 Sanofi-Aventis Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.3.5 Sanofi-Aventis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Dermatophytosis Therapeutics Introduction
11.4.4 Merck Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Enzon Pharmaceuticals
11.5.1 Enzon Pharmaceuticals Company Details
11.5.2 Enzon Pharmaceuticals Business Overview
11.5.3 Enzon Pharmaceuticals Dermatophytosis Therapeutics Introduction
11.5.4 Enzon Pharmaceuticals Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.5.5 Enzon Pharmaceuticals Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Dermatophytosis Therapeutics Introduction
11.6.4 Bayer Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Dermatophytosis Therapeutics Introduction
11.7.4 Astellas Pharma Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.7.5 Astellas Pharma Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Dermatophytosis Therapeutics Introduction
11.8.4 GSK Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.8.5 GSK Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Dermatophytosis Therapeutics Introduction
11.9.4 Abbott Revenue in Dermatophytosis Therapeutics Business (2016-2021)
11.9.5 Abbott Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dermatophytosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rx
Table 3. Key Players of OTC
Table 4. Global Dermatophytosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dermatophytosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dermatophytosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dermatophytosis Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Dermatophytosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dermatophytosis Therapeutics Market Share by Regions (2022-2027)
Table 10. Dermatophytosis Therapeutics Market Trends
Table 11. Dermatophytosis Therapeutics Market Drivers
Table 12. Dermatophytosis Therapeutics Market Challenges
Table 13. Dermatophytosis Therapeutics Market Restraints
Table 14. Global Dermatophytosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dermatophytosis Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Dermatophytosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytosis Therapeutics as of 2020)
Table 17. Ranking of Global Top Dermatophytosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dermatophytosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatophytosis Therapeutics Product Solution and Service
Table 21. Date of Enter into Dermatophytosis Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermatophytosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Dermatophytosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dermatophytosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dermatophytosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Dermatophytosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dermatophytosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dermatophytosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dermatophytosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dermatophytosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dermatophytosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dermatophytosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dermatophytosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dermatophytosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dermatophytosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dermatophytosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dermatophytosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dermatophytosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dermatophytosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dermatophytosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dermatophytosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dermatophytosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dermatophytosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dermatophytosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dermatophytosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dermatophytosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dermatophytosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dermatophytosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dermatophytosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dermatophytosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dermatophytosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dermatophytosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dermatophytosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dermatophytosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dermatophytosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Dermatophytosis Therapeutics Product
Table 64. Novartis Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Dermatophytosis Therapeutics Product
Table 69. Pfizer Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Sanofi-Aventis Company Details
Table 72. Sanofi-Aventis Business Overview
Table 73. Sanofi-Aventis Dermatophytosis Therapeutics Product
Table 74. Sanofi-Aventis Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Sanofi-Aventis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Dermatophytosis Therapeutics Product
Table 79. Merck Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Enzon Pharmaceuticals Company Details
Table 82. Enzon Pharmaceuticals Business Overview
Table 83. Enzon Pharmaceuticals Dermatophytosis Therapeutics Product
Table 84. Enzon Pharmaceuticals Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Enzon Pharmaceuticals Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Dermatophytosis Therapeutics Product
Table 89. Bayer Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Astellas Pharma Company Details
Table 92. Astellas Pharma Business Overview
Table 93. Astellas Pharma Dermatophytosis Therapeutics Product
Table 94. Astellas Pharma Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Astellas Pharma Recent Development
Table 96. GSK Company Details
Table 97. GSK Business Overview
Table 98. GSK Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 99. GSK Recent Development
Table 100. Abbott Company Details
Table 101. Abbott Business Overview
Table 102. Abbott Dermatophytosis Therapeutics Product
Table 103. Abbott Revenue in Dermatophytosis Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Abbott Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Rx Features
Figure 3. OTC Features
Figure 4. Global Dermatophytosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Dermatophytosis Therapeutics Report Years Considered
Figure 9. Global Dermatophytosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dermatophytosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dermatophytosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Dermatophytosis Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Dermatophytosis Therapeutics Market Share by Players in 2020
Figure 14. Global Top Dermatophytosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytosis Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dermatophytosis Therapeutics Revenue in 2020
Figure 16. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dermatophytosis Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Dermatophytosis Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Dermatophytosis Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dermatophytosis Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Dermatophytosis Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Dermatophytosis Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dermatophytosis Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dermatophytosis Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dermatophytosis Therapeutics Market Share by Region (2016-2027)
Figure 38. China Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dermatophytosis Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Dermatophytosis Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Dermatophytosis Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dermatophytosis Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dermatophytosis Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dermatophytosis Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dermatophytosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 59. Sanofi-Aventis Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 61. Enzon Pharmaceuticals Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 64. GSK Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in Dermatophytosis Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---